| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |